
| Company Name: | Pegasus Farmaco Pvt Ltd |
| OldName: | |
| Group : | |
| Address: | Corp Office |
| 1-3-183/40/B/1, S.B.I. Colony, | |
| Gandhi Nagar | |
| City: | Hyderabad 500080 Rangareddy Telangana |
| Tel: | 040 – 27620121, 65597185 |
| Fax: | 040 – 27672845 |
| Mktg-Email : | info@pegasusfarmaco.com |
| HR-Email : | |
| Purchase-Email : | pegasusfarmaco@yahoo.com |
| Brands Owned : |
About the Company :
Pegasus Farmaco Pvt Ltd is a pharmaceutical company based at Hyderabad, India. The company was incorporated in 1995 by Mr Raghuveer Beti, Ms. Neeraja Beti, Mr. Surinder Vuthoori and Ms. Indira Vuthoori. PFIPL is engaged in the manufacturing and marketing of branded and generic pharmaceutical formulations along with contract manufacturing for various clients. The company operates two manufacturing units at Roorkee, Uttarakhand (dedicated to tablets and capsules with separate Betalactum and Non Betalactum divisions) and Bhongir, Andhra Pradesh (dedicated to ointments and gels). Both the units are ISO 9001:2008 certified and meet World Health Organization Good Manufacturing Practices (WHO GMP standards).
The product portfolio includes wide range of formulations across all therapeutic segments (especially anti-biotic and pain management segments) in the form of capsules, tablets, syrups, drops and ointments and injectables. The company has technical collaboration with “Cipla Ltd” for manufacturing and marketing the formulations. The company has launched and promote the Cardio-diabetic products. PFIPL has successfully launched GLYCIPEG for Hypertension (HT) and Diabetes Mellitus (DM).
| Other Office Address |
| Plant Kasara No. 112, Matlabpur (V) Roorkee Roorkee 247667 Haridwar Uttaranchal Tel: 0133-269880 Fax: 0133-264551 Email: pegasusroorkee@yahoo.co.in |
| Plant 29, IDA, Bhongir, Nalgonda Bhongir 508116 Nalagonda Telangana Tel: 08685-645845 Email: pegasusderma@yahoo.com |
| Corp Office 1-3-183/40/B/1, S.B.I. Colony, Gandhi Nagar Hyderabad 500080 Rangareddy Telangana 040 – 27620121, 65597185 040 – 27672845 |
Leave a Reply